BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2441505)

  • 1. T antigen expression in benign hyperplasia and adenocarcinoma of the prostate.
    Moriyama H; Nakano H; Igawa M; Nihira H
    Urol Int; 1987; 42(2):120-3. PubMed ID: 2441505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of T antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate.
    Ghazizadeh M; Kagawa S; Izumi K; Kurokawa K
    J Urol; 1984 Dec; 132(6):1127-30. PubMed ID: 6209422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of carcinoembryonic antigen in benign hyperplasia and adenocarcinoma of the prostate with monoclonal antibody.
    Ghazizadeh M; Kagawa S; Izumi K; Maebayashi K; Takigawa H; Saiki T; Kawano A; Kurokawa K
    J Urol; 1984 Mar; 131(3):501-3. PubMed ID: 6199524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, N antigen precursor glycoproteins and T-active glycoproteins from cyst fluids of malignant ovarian clear cell carcinoma.
    Yanagi K; Ohyama K; Yamakawa T; Ohkuma S
    Int J Biochem; 1990; 22(9):1015-28. PubMed ID: 2282960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential histochemical peanut agglutinin stain in benign and malignant human prostate tumors: relationship with prostatic specific antigen immunostain and nuclear DNA content.
    Janssen T; Petein M; Van Velthoven R; Van Leer P; Fourmarier M; Vanegas JP; Danguy A; Schulman C; Pasteels JL; Kiss R
    Hum Pathol; 1996 Dec; 27(12):1341-7. PubMed ID: 8958309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thomsen-Friedenreich antigen in bladder cancer tissues detected by monoclonal antibody.
    Yokoyama M; Ohoka H; Oda H; Oda T; Utsumi S; Takeuchi M
    Hinyokika Kiyo; 1988 Feb; 34(2):255-8. PubMed ID: 3376817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines.
    Wolf MF; Koerner U; Schumacher K
    Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
    Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
    Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of soybean agglutinin lectin to prostatic hyperplasia and adenocarcinoma.
    Loy TS; Kyle J; Bickel JT
    Cancer; 1989 Apr; 63(8):1583-6. PubMed ID: 2466550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
    Ellis DW; Leffers S; Davies JS; Ng AB
    Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
    Stein R; Chen S; Grossman W; Goldenberg DM
    Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study on Thomsen-Friedenreich antigen in bladder tumor].
    Oda Y
    Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thomsen-Friedenreich-related antigen in non-neoplastic ureter urothelium and transitional cell tumours of the urinary bladder. An immunohistochemical study employing the monoclonal antibody 49H.8.
    Juhl BR; Hartzen SH; Hainau B
    Acta Pathol Microbiol Immunol Scand A; 1987 Mar; 95(2):83-91. PubMed ID: 3551496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of the T antigen and the cryptic T antigen in rat fetuses: detection with the lectin amaranthin.
    Sata T; Zuber C; Rinderle SJ; Goldstein IJ; Roth J
    J Histochem Cytochem; 1990 Jun; 38(6):763-74. PubMed ID: 2335739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for T-antigen demonstration by a polyclonal antibody and peanut lectin; elimination of cross-reaction with naturally occurring antibodies.
    Orntoft TF
    Virchows Arch A Pathol Anat Histopathol; 1984; 404(2):159-66. PubMed ID: 6435306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.
    Brenner PC; Rettig WJ; Sanz-Moncasi MP; Reuter V; Aprikian A; Old LJ; Fair WR; Garin-Chesa P
    J Urol; 1995 May; 153(5):1575-9. PubMed ID: 7536270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.
    Ohoka H; Shinomiya H; Yokoyama M; Ochi K; Takeuchi M; Utsumi S
    Urol Res; 1985; 13(2):47-50. PubMed ID: 4012935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachromasia in the human prostate: a histochemical difference between benign prostatic hyperplasia and prostatic carcinoma.
    Arcadi JA
    J Urol; 1988 Feb; 139(2):315-7. PubMed ID: 2448498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.